HHS proposes rule to prevent sale of hematopoietic stem cells

10/3/2013 | MedPage Today (free registration)

The Department of Health and Human Services is calling for the inclusion of apheresis-acquired hematopoietic stem cells under the definition of "human organ" in an effort to prevent the sale of HSCs for profit. The proposed rule includes a penalty of up to $50,000 and a maximum of five years' imprisonment to those who attempt to make money from the transfer of HSCs. The changes would amend the current definition of human organ, which covers bone marrow "or any subpart thereof," under the National Organ and Transplantation Act of 1984.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD